Australia’s most read investor-focused magazine for ASX-listed Tech & Biotech stocks
Trending Stories
12 March, 2024
IKE secures another significant multi-year subscription deal
IkeGPS Group Limited (ASX:IKE) or IKE, has announced it has entered into a five year agreement with the second largest electric utility in the U.S., upgrading them from IKE’s legacy product to its...
29 February, 2024
Proteomics granted European patent for OxiDx technology
Predictive diagnostics pioneer Proteomics International Laboratories’ (ASX: PIQ) subsidiary OxiDx Pty Ltd has been granted a patent in 19 major European countries for its platform technology to...
28 February, 2024
LGP sends first Polish cannabis flower shipment
Little Green Pharma Ltd (ASX: LGP) has shipped its first batch of LGP- branded high-THC Desert Flame cannabis flower products to Poland.
26 February, 2024
LGP welcomes German decision to legalise cannabis
Little Green Pharma (ASX: LGP) has welcomed historic move of the German Bundestag to vote to legalise cannabis by removing it from the Narcotics List from 1 April 2024. This represents the most...
Latest News
Latest Web & Podcasts
Book Now for the Next Edition
Reach real investors through TechInvest Magazine, distributed as an independent insert in The Australian Financial Review, online via www.techinvest.online as well as across investor-focused social media channels.
Book now for TechInvest Edition 4, coming in 2024 with many opportunities to showcase your Tech insights.
What you get:
- Article on your company written by a highly experienced writer or supplied by your company
- Approved article included in TechInvest and replicated on www.techinvest.online
- Two page ‘Company in Focus’ features receive prominent pointer on front page of magazine
- Copy of article (copyright free) for you to use for own marketing purposes
- 10 copies of magazine